Jim Cramer recently discussed Constellation Brands, Inc. (NYSE:STZ), a stock that has lost 24% year-to-date. The firm missed revenue and EPS estimates in its fiscal third quarter, leading to a cut in fiscal year guidance. Cramer expressed concerns about dropping alcohol consumption and the impact of GLP-1 drugs on the stock.

Cramer was not optimistic about Constellation Brands, Inc. (NYSE:STZ) ahead of its latest earnings. The company’s products, including Modelo and Corona beers, are being hurt by GLP-1 drugs, which reduce cravings for alcohol. The switch from beer to cannabis due to health concerns and sales impact from Hispanic community deportation fears have contributed to the stock’s decline.

Read more at Yahoo Finance: Constellation Brands, Inc. (STZ)’s “A Terrible Stock,” Says Jim Cramer